A citation-based method for searching scientific literature

Katherine R Tuttle, Frank C Brosius, Matthew A Cavender, Paola Fioretto, Kevin J Fowler, Hiddo J L Heerspink, Tom Manley, Darren K McGuire, Mark E Molitch, Amy K Mottl, Leigh Perreault, Sylvia E Rosas, Peter Rossing, Laura Sola, Volker Vallon, Christoph Wanner, Vlado Perkovic. Diabetes 2021
Times Cited: 6







List of co-cited articles
8 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Dapagliflozin in Patients with Chronic Kidney Disease.
Hiddo J L Heerspink, Bergur V Stefánsson, Ricardo Correa-Rotter, Glenn M Chertow, Tom Greene, Fan-Fan Hou, Johannes F E Mann, John J V McMurray, Magnus Lindberg, Peter Rossing,[...]. N Engl J Med 2020
560
83

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
50

Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease: A Scientific Statement From the American Heart Association.
Janani Rangaswami, Vivek Bhalla, Ian H de Boer, Alexander Staruschenko, Johanna A Sharp, Radhika Rajgopal Singh, Kevin Bryan Lo, Katherine Tuttle, Muthiah Vaduganathan, Hector Ventura,[...]. Circulation 2020
30
33

Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus.
David Z I Cherney, Bruce A Perkins, Nima Soleymanlou, Maria Maione, Vesta Lai, Alana Lee, Nora M Fagan, Hans J Woerle, Odd Erik Johansen, Uli C Broedl,[...]. Circulation 2014
732
33

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.
Christoph Wanner, Silvio E Inzucchi, John M Lachin, David Fitchett, Maximilian von Eynatten, Michaela Mattheus, Odd Erik Johansen, Hans J Woerle, Uli C Broedl, Bernard Zinman. N Engl J Med 2016
33

Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries.
Katherine T Mills, Joshua D Bundy, Tanika N Kelly, Jennifer E Reed, Patricia M Kearney, Kristi Reynolds, Jing Chen, Jiang He. Circulation 2016
33

2018 ESC/ESH Guidelines for the management of arterial hypertension.
Bryan Williams, Giuseppe Mancia, Wilko Spiering, Enrico Agabiti Rosei, Michel Azizi, Michel Burnier, Denis L Clement, Antonio Coca, Giovanni de Simone, Anna Dominiczak,[...]. Eur Heart J 2018
33

The Global Epidemiology of Diabetes and Kidney Disease.
Digsu N Koye, Dianna J Magliano, Robert G Nelson, Meda E Pavkov. Adv Chronic Kidney Dis 2018
95
33

Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial.
David C Wheeler, Bergur V Stefánsson, Niels Jongs, Glenn M Chertow, Tom Greene, Fan Fan Hou, John J V McMurray, Ricardo Correa-Rotter, Peter Rossing, Robert D Toto,[...]. Lancet Diabetes Endocrinol 2021
53
16

Diabetic Kidney Disease: Challenges, Progress, and Possibilities.
Radica Z Alicic, Michele T Rooney, Katherine R Tuttle. Clin J Am Soc Nephrol 2017
544
16

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).
Amanda I Adler, Richard J Stevens, Sue E Manley, Rudy W Bilous, Carole A Cull, Rury R Holman. Kidney Int 2003
16

Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials.
Vlado Perkovic, Dick de Zeeuw, Kenneth W Mahaffey, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Terrance D Barrett, Michele Weidner-Wells, Hsiaowei Deng, David R Matthews,[...]. Lancet Diabetes Endocrinol 2018
247
16

SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition.
Issei Tomita, Shinji Kume, Sho Sugahara, Norihisa Osawa, Kosuke Yamahara, Mako Yasuda-Yamahara, Naoko Takeda, Masami Chin-Kanasaki, Tatsuroh Kaneko, Eric Mayoux,[...]. Cell Metab 2020
47
16

Long-term treatment with the sodium glucose cotransporter 2 inhibitor, dapagliflozin, ameliorates glucose homeostasis and diabetic nephropathy in db/db mice.
Naoto Terami, Daisuke Ogawa, Hiromi Tachibana, Takashi Hatanaka, Jun Wada, Atsuko Nakatsuka, Jun Eguchi, Chikage Sato Horiguchi, Naoko Nishii, Hiroshi Yamada,[...]. PLoS One 2014
175
16

Investigation and identification of etiologies involved in the development of acquired hydronephrosis in aged laboratory mice with the use of high-frequency ultrasound imaging.
Danielle A Springer, Michele Allen, Victoria Hoffman, Lauren Brinster, Matthew F Starost, Mark Bryant, Michael Eckhaus. Pathobiol Aging Age Relat Dis 2014
10
16


A new, easily generated mouse model of diabetic kidney fibrosis.
Xiaolin He, Tianzhou Zhang, Monica Tolosa, Santosh Kumar Goru, Xiaolan Chen, Paraish S Misra, Lisa A Robinson, Darren A Yuen. Sci Rep 2019
6
16

Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis.
Benjamin D Humphreys, Fengfeng Xu, Venkata Sabbisetti, Ivica Grgic, Said Movahedi Naini, Ningning Wang, Guochun Chen, Sheng Xiao, Dhruti Patel, Joel M Henderson,[...]. J Clin Invest 2013
196
16

Transgenic mice overexpressing Renin exhibit glucose intolerance and diet-genotype interactions.
Sarah J Fletcher, Nishan S Kalupahana, Morvarid Soltani-Bejnood, Jung Han Kim, Arnold M Saxton, David H Wasserman, Bart De Taeye, Brynn H Voy, Annie Quignard-Boulange, Naima Moustaid-Moussa. Front Endocrinol (Lausanne) 2013
8
16

Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes.
H J Lambers Heerspink, D de Zeeuw, L Wie, B Leslie, J List. Diabetes Obes Metab 2013
433
16

Molecular mechanisms of diabetic kidney disease.
Kimberly Reidy, Hyun Mi Kang, Thomas Hostetter, Katalin Susztak. J Clin Invest 2014
387
16

Renal Anti-Fibrotic Effect of Sodium Glucose Cotransporter 2 Inhibition in Angiotensin II-Dependent Hypertension.
Giovanna Castoldi, Raffaella Carletti, Silvia Ippolito, Massimiliano Colzani, Francesca Barzaghi, Andrea Stella, Gianpaolo Zerbini, Gianluca Perseghin, Cira R T di Gioia. Am J Nephrol 2020
10
16

Use of labeled tomato lectin for imaging vasculature structures.
Richard T Robertson, Samantha T Levine, Sherry M Haynes, Paula Gutierrez, Janie L Baratta, Zhiqun Tan, Kenneth J Longmuir. Histochem Cell Biol 2015
83
16



Prediction of prevalence of chronic kidney disease in diabetic patients in countries of the European Union up to 2025.
Alexander Kainz, Milan Hronsky, Vianda S Stel, Kitty J Jager, Angelika Geroldinger, Daniela Dunkler, Georg Heinze, Giovanni Tripepi, Rainer Oberbauer. Nephrol Dial Transplant 2015
35
16

Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial.
David Z I Cherney, Claire C J Dekkers, Sean J Barbour, Daniel Cattran, Abdul Halim Abdul Gafor, Peter J Greasley, Gozewijn D Laverman, Soo Kun Lim, Gian Luca Di Tanna, Heather N Reich,[...]. Lancet Diabetes Endocrinol 2020
51
16

Obstructive uropathy and hydronephrosis in male KK-Ay mice: a report of cases.
H Ninomiya, T Inomata, K Ogihara. J Vet Med Sci 1999
15
16

Diabetic kidney disease.
Merlin C Thomas, Michael Brownlee, Katalin Susztak, Kumar Sharma, Karin A M Jandeleit-Dahm, Sophia Zoungas, Peter Rossing, Per-Henrik Groop, Mark E Cooper. Nat Rev Dis Primers 2015
204
16


Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice.
Linda A Gallo, Micheal S Ward, Amelia K Fotheringham, Aowen Zhuang, Danielle J Borg, Nicole B Flemming, Ben M Harvie, Toni L Kinneally, Shang-Ming Yeh, Domenica A McCarthy,[...]. Sci Rep 2016
7
16


Progressive Renal Disease Established by Renin-Coding Adeno-Associated Virus-Driven Hypertension in Diverse Diabetic Models.
Shannon M Harlan, Kathleen M Heinz-Taheny, John M Sullivan, Tao Wei, Hana E Baker, Dianna L Jaqua, Zhonghua Qi, Martin S Cramer, Tatiyana L Shiyanova, Matthew D Breyer,[...]. J Am Soc Nephrol 2018
12
16

Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice.
Bowen Lin, Nobutaka Koibuchi, Yu Hasegawa, Daisuke Sueta, Kensuke Toyama, Ken Uekawa, MingJie Ma, Takashi Nakagawa, Hiroaki Kusaka, Shokei Kim-Mitsuyama. Cardiovasc Diabetol 2014
188
16

Characterisation of age-dependent beta cell dynamics in the male db/db mice.
Louise S Dalbøge, Dorthe L C Almholt, Trine S R Neerup, Efstathios Vassiliadis, Niels Vrang, Lars Pedersen, Keld Fosgerau, Jacob Jelsing. PLoS One 2013
53
16

Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury.
Fiona Chow, Elyce Ozols, David J Nikolic-Paterson, Robert C Atkins, Gregory H Tesch. Kidney Int 2004
368
16


Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors.
Ralph A DeFronzo, W Brian Reeves, Alaa S Awad. Nat Rev Nephrol 2021
25
16

DBA2J db/db mice are susceptible to early albuminuria and glomerulosclerosis that correlate with systemic insulin resistance.
Mette V Østergaard, Vanda Pinto, Kirsty Stevenson, Jesper Worm, Lisbeth N Fink, Richard J M Coward. Am J Physiol Renal Physiol 2017
12
16

Angiotensin-converting enzyme inhibitors.
N J Brown, D E Vaughan. Circulation 1998
440
16

Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging.
Kengo Kidokoro, David Z I Cherney, Andrea Bozovic, Hajime Nagasu, Minoru Satoh, Eiichiro Kanda, Tamaki Sasaki, Naoki Kashihara. Circulation 2019
99
16

A genetically clamped renin transgene for the induction of hypertension.
Kathleen M I Caron, Leighton R James, Hyung-Suk Kim, Scott G Morham, Maria Luisa S Sequeira Lopez, R Ariel Gomez, Timothy L Reudelhuber, Oliver Smithies. Proc Natl Acad Sci U S A 2002
55
16

Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury.
Annayya R Aroor, Nitin A Das, Andrea J Carpenter, Javad Habibi, Guanghong Jia, Francisco I Ramirez-Perez, Luis Martinez-Lemus, Camila M Manrique-Acevedo, Melvin R Hayden, Cornel Duta,[...]. Cardiovasc Diabetol 2018
60
16

CV Protection in the EMPA-REG OUTCOME Trial: A "Thrifty Substrate" Hypothesis.
Ele Ferrannini, Michael Mark, Eric Mayoux. Diabetes Care 2016
512
16

Pathological and Transcriptome Changes in the ReninAAV db/ db uNx Model of Advanced Diabetic Kidney Disease Exhibit Features of Human Disease.
Shannon M Harlan, Kathleen M Heinz-Taheny, Jessica M Overstreet, Matthew D Breyer, Raymond C Harris, Josef G Heuer. Toxicol Pathol 2018
3
33

Diagnosis of diabetic kidney disease: state of the art and future perspective.
Frederik Persson, Peter Rossing. Kidney Int Suppl (2011) 2018
87
16

Role of sodium/glucose cotransporter inhibition on a rat model of angiotensin II-dependent kidney damage.
Humberto Reyes-Pardo, Rocío Bautista, Hilda Vargas-Robles, Amelia Rios, Daniel Sánchez, Bruno Escalante. BMC Nephrol 2019
6
16

Impact of age at administration, lysosomal storage, and transgene regulatory elements on AAV2/8-mediated rat liver transduction.
Gabriella Cotugno, Patrizia Annunziata, Maria Vittoria Barone, Marianthi Karali, Sandro Banfi, Alberto Auricchio. PLoS One 2012
13
16

Impact of sex on diabetic nephropathy and the renal transcriptome in UNx db/db C57BLKS mice.
Frederikke E Sembach, Lisbeth N Fink, Thea Johansen, Brandon B Boland, Thomas Secher, Sebastian T Thrane, Jens C Nielsen, Keld Fosgerau, Niels Vrang, Jacob Jelsing,[...]. Physiol Rep 2019
5
20

Transcutaneous measurement of renal function in conscious mice.
Andrea Schreiber, Yury Shulhevich, Stefania Geraci, Juergen Hesser, Dzmitry Stsepankou, Sabine Neudecker, Stefan Koenig, Ralf Heinrich, Friederike Hoecklin, Johannes Pill,[...]. Am J Physiol Renal Physiol 2012
108
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.